Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India

Biological and Chemical Indicators Market

Biological and Chemical Indicators Market Snapshot

The global biological and chemical indicators market is set to value at US$ 490.3 million in 2023. With an estimated growth rate of 5.9% CAGR during the forecast period, the market is likely to surpass US$ 866.9 million by 2033. The increasing emphasis on patient safety and infection control in the healthcare sector drives the demand for biological and chemical indicators. Some factors driving the market growth include:

  • With the growing prevalence of HAIs, hospitals, and clinics invest in sterilization equipment and solutions to prevent the spreading infections.
  • The increasing number of surgical procedures and the need for sterile medical devices also drive the sales of biological and chemical indicators.
  • The rise in the number of dental clinics and laboratories is also contributing to the growth of this market.
  • The biological and chemical indicators industry is witnessing an increasing demand due to the growing awareness regarding the importance of sterilization procedures in healthcare facilities. The rise in hospital-acquired infections (HAIs) is a major factor contributing to the growth of this market.
  • The demand for biological indicators is expected to grow significantly due to their accuracy and reliability in monitoring the effectiveness of thermal sterilization processes.
  • Adopting chemical sterilization methods also drives the demand for chemical indicators.
Data Points Market Insights
Market Value 2023 US$ 490.3 million
Market Value 2033 US$ 866.9 million
CAGR 2023 to 2033 5.9%
Share of Top 5 Countries 61.4%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Capitalizing on the Latest Innovations: Exploring the Booming Demand for Biological and Chemical Indicators

The biological and chemical indicators industry is witnessing several innovations in terms of product development and technological advancements. The development of self-contained biological indicators and the integration of electronic monitoring systems are some of the innovations in this market.

The use of biological indicators in the food and beverage processing industries is also expected to provide significant growth opportunities for players in this market. In addition, the increasing adoption of chemical sterilization methods is expected to drive the demand for chemical indicators, creating opportunities for market players to develop new and innovative products.

The sales of biological and chemical indicators are expected to be driven by the increasing awareness of the importance of sterilization procedures in healthcare facilities. The demand for biological indicators is expected to witness significant growth due to their accuracy and reliability in monitoring the effectiveness of thermal sterilization processes.

The adoption of chemical sterilization methods is also driving the demand for chemical indicators. This market is witnessing several innovations in terms of product development and technological advancements, creating opportunities for players to develop new and innovative products. With the increasing emphasis on patient safety and infection control in the healthcare sector, the biological and chemical indicators industry is expected to witness significant growth during the forecast period.

2017 to 2022 Biological and Chemical Indicators Market Demand Outlook Compared to 2023 to 2033 forecast

As projected by Future Market Insights, the biological indicators by indicator class are estimated to see a market value of US$ 393.2 million, which shows more than half of the total biological and chemical indicators industry in 2022.

The increasing adoption rate of universal sterilization indicators, increasing advanced product development, rising commercialization of parenteral therapeutics, diagnosing disease, and development of In-house sterilization monitoring solutions are the primary factors boosting the development of the biological and chemical indicators industry.

The biological and chemical indicators market holds nearly 10.4% of the market value share of the US$ 4.1 billion sterilization market in 2021. In addition, collaborative efforts and initiatives to do efficient workflow and the emerging trend of exploring next-generation techniques are expected to lead to rapid growth in the biological and chemical indicators industry.

Particulars Details
H1, 2021 7.28%
H1, 2022 Projected 7.28%
H1, 2022 Outlook 7.28%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 10 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (-) 13 ↓

According to FMI, the biological and chemical indicators market is likely to dip in the BPS change by nearly 13 basis point share (BPS) in H1-2022 (O) compared to H1-2021. Furthermore, variation in BPS change is also observed by comparing the H1-2022 outlook and H1-2022 projected period by nearly 10 BPS.

The shortcomings of rapid biological indicators include that under unfavorable conditions such as temperature variation, the period available to detect fluorescence is not adequate, thus presenting with lower output than expected. This factor is associated with several disadvantages to the market.

The underdeveloped regions have limitations regarding the resources and capabilities for sterilization procedures and monitoring, which contributes to the BPS value reduction.

The growth rates and development possibilities of the global biological and chemical indicators industry have been analyzed by FMI. The market is subject to be influenced by quality assessment, regulations, and the impact of macro and industrial variables.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

FMI expects the global biological and chemical indicators industry to grow at a CAGR of 5.9% through 2033

The growing risk of infections during surgeries and hospital-acquired infections creates a huge demand for safety and hygiene in the sterile production process. Numerous hygiene awareness programs in various regions to promote the use of sterile instruments and equipment is likely to create opportunities in the biological and chemical indicators industry shortly.

For Instance, the Georgia Environmental Protection Division (EPD) and USA Environmental Protection Agency (EPA) gave joint protocol to provide support by increasing the production at sterilization facilities in Covington and Madison during COVID there was high demand and short supply for sterile medical equipment.

Surgical care is essential to manage diverse health conditions, such as injuries, malignancy, infections, and cardiovascular diseases. An increase in the number of surgical procedures is likely to directly impact the sale of biological and chemical indicators. According to a WHO study, in 2020, around 310 million surgical procedures were used to address the burden of different diseases for the global population.

Comparative View of the Biological and Chemical Indicators Market

Biological and Chemical Indicators Market:

Attributes Biological and Chemical Indicators Market
CAGR (2023 to 2033) 5.9%
Market Value (2033) US$ 866.9 million
Opportunity Increasing awareness and adoption of quality assurance and control measures in healthcare facilities.
Key Trends Growing demand for rapid microbial detection systems in the pharmaceutical and biotechnology industries.

Sterility Indicators Market:

Attributes Sterility Indicators Market
CAGR (2023 to 2033) 11.4%
Market Value (2033) US$ 2,750 million
Opportunity Technological advancements in sterilization indicators and increased funding for healthcare infrastructure in developing countries.
Key Trends Rising need for sterilization of medical devices and equipment in healthcare settings.

Sterilization Monitoring Market:

Attributes Sterilization Monitoring Market
CAGR (2023 to 2033) 7.50%
Market Value (2033) US$ 1,398.05 million
Opportunity The increasing adoption of single-use medical devices and the rise in healthcare-associated infections drive the need for sterilization monitoring.
Key Trends Growing demand for ethylene oxide sterilization monitoring due to its effectiveness against a wide range of microorganisms.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Which Factors Are Restraining Demand for Biological and Chemical Indicators?

Inconvenience, long waiting times for results, sub-standard sterilization practices, and increasing adoption of disposable biological and chemical indicators are the key factors restraining the market growth over the forecast period.

The classical sterilization indicators, such as biological indicators, take a longer period, about 7 days, to show results. In addition, chemical indicators can give false positive results and are generally not recommended by healthcare regulatory agencies. This disadvantage of classic sterilization indicators is expected to hamper the adoption rate of the products.

Underdeveloped regions have limited resources and capabilities for sterilization procedures and monitoring. In the non-regulated market, several professionals rely on non-validated sterilization procedures or violate standard sterilization protocols. Such practices are expected to reduce the use of sterilization indicators during sterilization procedures, a major factor restraining the market.

Country-wise Insights

What Makes the United States a Large Market for Biological and Chemical Indicators?

United States Market Size (US$ million) by End of Forecast Period (2033) US$ 169.4 million
CAGR % 2023 to End of Forecast (2033) 4.9%

The United States biological and chemical indicators industry is expected to reach a valuation of US$ 169.4 million by the end of the forecast period in 2033, with a CAGR of 4.9% between 2023 and 2033.

The dominant share of the United States can mainly be due to the launch of technologically advanced products, regulatory stringency and compliance, and increasing discretionary funding for cancer research. With advancements in manufacturing and digitalization, healthcare professionals expect customized sterilization indicator solutions in sterilization monitoring operations.

Several innovative biological and chemical indicator suppliers in the United States market are offering customized services of sterilization indicators specific to the need of the end users. This driver is expected to provide a competitive edge for the players in the market.

For example, Sterilization Indicators contract manufacturer (OME) and Propper Manufacturing Co., Inc., United States, offer multiple packaging forms and indicators for customization needs to healthcare end users. These include cost-effective, environmentally friendly, tailored to specific customer needs, and maintaining ISO and FDA compliance.

Regulatory authorities of regulated markets such as the United States and ISO regions have issued separate guidelines on the regulatory requirements of the sterilization validation procedures for compliance with the sterilization procedures. This regulatory stringency is expected to increase the demand for biological and chemical indicators across the global and United States market.

Why is Europe Considered a Lucrative Region for the Biological and Chemical Indicators Industry?

Europe Region Analysis Value and CAGR
Germany Market Size (US$ million) by End of Forecast Period (2033) US$ 20.7 million
CAGR % 2023 to End of Forecast (2033) 3.7%
United Kingdom Market Size (US$ million) by End of Forecast Period (2033) US$ 19.5 million
CAGR % 2023 to End of Forecast (2033) 6.0%

In Germany, the biological and chemical indicators market is predicted to reach a valuation of US$ 20.7 million by 2033, with a CAGR of 3.7% from 2023 to 2033. German companies have a strong focus and continuous investments in research and technological advancement for developing and commercializing rapid sterilization monitoring products. These are expected to raise the adoption of biological indicators due to their high speed and high efficacy features.

The United Kingdom biological and chemical indicators market is estimated to be valued at US$ 19.5 million by 2033, with a CAGR of 6.0% during the forecast period.

For instance, Protak Scientific Ltd., a Europe-based innovative startup, invented and commercialized a new class of sterilization indicators known as Enzyme Indicators. The product uses a thermostable Adenylate kinase (tAK) enzyme isolated from thermophilic bacteria found in hot springs (Sulpholobus acidocaldarius).

What are the Factors Fueling the Demand for Biological and chemical indicators in China?

China Market Size (US$ million) by End of Forecast Period (2033) US$ 32.7 million
CAGR % 2023 to End of Forecast (2033) 5.3%

China's biological and chemical indicators market is projected to attain a value of US$ 32.7 million by the end of the forecast period in 2033, with a CAGR of 5.3% from 2023 to 2033. Increasing community and hospital-acquired infections create opportunities for biological and chemical indicators in the Chinese market.

The biopharmaceutical industry is actively engaged in the development of novel biologics and sensitive products. Among the newly commercialized biologics, the majority of therapeutics are formulated in the parenteral dosage form. This increase in parenteral dosage manufacturing volume across the biopharmaceutical industry is expected to fuel the growth of China's biological and chemical indicators industry.

How is the Biological and Chemical Indicators Industry Anticipated to Expand across India?

In 2022, India's demand for biological and chemical indicators was expected to grow at a market share of 72.0%. Outsourcing of biopharma research is done extensively in emerging countries like India. The clinical trial partnership of various key players with emerging companies to speed up the clinical trial process is rising. The partnership is expected to help both companies to achieve the best results in less time. Such partnership agreements amongst players are likely to help gain traction in the Indian market.

Category-wise Insights

High Demand for Thermal Sterilization Makes it the Leading Segment in the Market

Top Sterilization Type Thermal Sterilization
CAGR % 2023 to End of Forecast (2033) 6.9%

By sterilization type, thermal sterilization is anticipated to hold the largest share of 69.4% in 2022. The segment is anticipated to record a CAGR of 6.9% during the forecast period. This is due to a significant preference for steam heat sterilization over other sterilization types owing to a high possibility of toxicity, handling risk, and environmental pollution associated with other sterilization types. Thermal sterilization uses the thermal liability of a microorganism to prevent its growth. Hence growing popularity and demand for this segment make it the leading one.

Why are Biological Indicators Anticipated to Hold the Maximum Market Share?

By indicator class, biological indicators are likely to lead the market and are projected to account for 85.8% of the total market revenue share in 2022.

The biological indicators segment is widely dominated due to regulatory recommendations to use biological indicators instead of chemical ones to achieve a high standard of sterility assurance. In addition, increasing commercialization of user-friendly biological indicators with rapid sterilization validation compliance is a key factor in the rising biological indicators adoption rate.

Demand for Self-Contained BI Continues Gaining Traction by form.

By form, self-contained BI is anticipated to hold the largest share of 42.0% in 2022. The high flexibility and efficiency of self-contained BI to deliver rapid results and an overall increase in operational efficiency leads this segment to hold the highest share.

Why is Biopharma End User Segment Projected Maximum Growth in the Biological and Chemical Indicators Industry?

Top End User Biopharma Industry
CAGR % 2023 to End of Forecast (2033) 4.8%

By End User, the biopharma industry is anticipated to hold nearly half of the global market share in revenue in 2022. The biopharma industry is anticipated to maintain the lead with a CAGR of 4.8% during the forecast period.

Among all end users, the biopharma industry is a leading segment that hospitals follow. The rising parenteral formulation, including new (biologics/synthetics) and generic formulations and stringent regulatory compliance requirements of sterilization validation, is rising the demand for sterilization indicators in the biopharmaceutical industry.

Disinfecting the Competition: Innovations and Challenges in the Biological and Chemical Indicators Industry

Companies operating in the biological and chemical indicators industry are naturally fragmented, with few players. These players are involved in several strategic alliances. The agreement and system automation accelerates the manufacturer’s strategy to capitalize on the market share and capture a significant market share.

Innovation is a major driver of growth in the biological and chemical indicators industry, with players continuously investing in research and development to improve their offerings. For instance, STERIS plc recently introduced a new range of chemical indicators that provide accurate and reliable monitoring of sterilization processes. Similarly, 3M Company has developed a unique biological indicator system that can detect the presence of spores in just one hour.

One of the major challenges facing players in the biological and chemical indicators industry is the need for stringent regulatory compliance. Companies need to adhere to various regulatory guidelines to ensure the safety and efficacy of their products. To address this challenge, players invest heavily in quality control and assurance measures to maintain compliance with regulatory standards.

Another challenge facing players in the industry is the increasing competition and pricing pressures. With new players entering the market, existing players need to differentiate themselves by offering unique value propositions and competitive pricing strategies. Companies invest in marketing and branding initiatives to address this challenge to increase brand awareness and market share.

Latest Developments in the Biological and Chemical Indicators Industry:

  • In 2020, Thermo Fisher Scientific, Inc. announced the acquisition of QIAGEN N.V. at approximately US$ 11.5 billion.
  • In July 2020, 3M company announced Attest Mini Auto-reader 490M, a 24-minute in-house sterilization monitoring solution, the technology designed for dental professionals' use.

Scope of the Report

Attribute Details
Forecast Period 2017 to 2022
Historical Data Available for 2023 to 2033
Market Analysis US$ million for Value
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, Nordic, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC Countries, South Africa, Turkey
Key Segments Covered Sterilization Type, Indicator Class, Packaging Form, End User, and Region
Key Companies Profiled
  • The 3M Company
  • Steris Plc.
  • Thermo Fisher Scientific, Inc.
  • Mesa Labs, Inc.
  • McKesson Medical-Surgical Inc.
  • Crosstex International, Inc.
  • Propper Manufacturing Co., Inc.
  • Terragene S.A.
  • Andersen Products, Inc.
  • Getinge AB
  • GKE-GmbH
  • Liofilchem S.r.l. /li>
  • Protak Scientific Ltd.
  • ParaSure Limited
  • Excelsior Scientific
  • Siltex Australia Pvt. Ltd.
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Biological and Chemical Indicators Market by Category

By Sterilization Type:

  • Thermal Sterilization
    • Steam Heat
    • Dry Heat
  • Chemical Sterilization
    • Ethylene Oxide
    • Hydrogen Peroxide
    • Formaldehyde
  • Radiation Sterilization

By Indicator Class:

  • Biological Indicators
    • Geobacillus stearothermophilus (GS) Spores
    • Bacillus atrophaeus (BA) Spores
    • Others
  • Chemical Indicators
    • Class 1 (Process)
    • Class 4 (Multi-Variable)
    • Class 2 (Specific-Use)
    • Class 3 (Single-Variable)
    • Class 5 (Integrating)
    • Class 6 (Cycle Verification)
  • Enzyme Indicators

By Packaging Form:

  • Self-Contained BI
  • Spore Suspension BI
  • Strip and Disc BI
  • Strip and Disc CI
  • Others

By End User:

  • Biopharma Industry
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Labs
  • Research Lab

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle-East & Africa

Frequently Asked Questions

The Biological and Chemical Indicators Market is set to attain a value of US$ 490.3 million in 2023.

The Biological and Chemical Indicators Market is estimated to surpass US$ 866.9 million by 2033.

The Biological and Chemical Indicators Market is projected to experience a CAGR of 5.9% through 2033.

Chinese population growth, rising healthcare costs, sepsis prevalence, and rising PCT assay knowledge all contribute to the country's market expansion.

The need for point-of-care services, the focus on patient safety, and technological advancements all contribute to the market's positive historical performance.

Table of Content

1. Executive Summary | Biological and Chemical Indicators Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sterilization Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Sterilization Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sterilization Type, 2023 to 2033

        5.3.1. Thermal Sterilization

            5.3.1.1. Steam Heat

            5.3.1.2. Dry Heat

        5.3.2. Chemical Sterilization

            5.3.2.1. Ethylene Oxide

            5.3.2.2. Hydrogen Peroxide

            5.3.2.3. Formaldehyde

        5.3.3. Radiation Sterilization

    5.4. Y-o-Y Growth Trend Analysis By Sterilization Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Sterilization Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indicator Class

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Indicator Class, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indicator Class, 2023 to 2033

        6.3.1. Biological Indicators

            6.3.1.1. Geobacillus stearothermophilus (GS) Spores

            6.3.1.2. Bacillus atrophaeus (BA) Spores

        6.3.2. Chemical Indicators

            6.3.2.1. Class 1 (Process)

            6.3.2.2. Class 4 (Multi-Variable)

            6.3.2.3. Class 2 (Specific-Use)

            6.3.2.4. Class 3 (Single-Variable)

            6.3.2.5. Class 5 (Integrating)

            6.3.2.6. Class 6 (Cycle Verification)

        6.3.3. Enzyme Indicators

    6.4. Y-o-Y Growth Trend Analysis By Indicator Class, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Indicator Class, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033

        7.3.1. Biopharma Industry

        7.3.2. Hospital & Clinics

        7.3.3. Ambulatory Surgical Centres

        7.3.4. Diagnostic Labs

        7.3.5. Research Labs

    7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Sterilization Type

        9.2.3. By Indicator Class

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Sterilization Type

        9.3.3. By Indicator Class

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Sterilization Type

        10.2.3. By Indicator Class

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Sterilization Type

        10.3.3. By Indicator Class

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Sterilization Type

        11.2.3. By Indicator Class

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Sterilization Type

        11.3.3. By Indicator Class

        11.3.4. By End User

    11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Sterilization Type

        12.2.3. By Indicator Class

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Sterilization Type

        12.3.3. By Indicator Class

        12.3.4. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Sterilization Type

        13.2.3. By Indicator Class

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Sterilization Type

        13.3.3. By Indicator Class

        13.3.4. By End User

    13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Sterilization Type

        14.2.3. By Indicator Class

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Sterilization Type

        14.3.3. By Indicator Class

        14.3.4. By End User

    14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Sterilization Type

        15.2.3. By Indicator Class

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Sterilization Type

        15.3.3. By Indicator Class

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Sterilization Type

            16.1.2.2. By Indicator Class

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Sterilization Type

            16.2.2.2. By Indicator Class

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Sterilization Type

            16.3.2.2. By Indicator Class

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Sterilization Type

            16.4.2.2. By Indicator Class

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Sterilization Type

            16.5.2.2. By Indicator Class

            16.5.2.3. By End User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Sterilization Type

            16.6.2.2. By Indicator Class

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Sterilization Type

            16.7.2.2. By Indicator Class

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Sterilization Type

            16.8.2.2. By Indicator Class

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Sterilization Type

            16.9.2.2. By Indicator Class

            16.9.2.3. By End User

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Sterilization Type

            16.10.2.2. By Indicator Class

            16.10.2.3. By End User

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Sterilization Type

            16.11.2.2. By Indicator Class

            16.11.2.3. By End User

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Sterilization Type

            16.12.2.2. By Indicator Class

            16.12.2.3. By End User

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Sterilization Type

            16.13.2.2. By Indicator Class

            16.13.2.3. By End User

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Sterilization Type

            16.14.2.2. By Indicator Class

            16.14.2.3. By End User

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Sterilization Type

            16.15.2.2. By Indicator Class

            16.15.2.3. By End User

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Sterilization Type

            16.16.2.2. By Indicator Class

            16.16.2.3. By End User

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Sterilization Type

            16.17.2.2. By Indicator Class

            16.17.2.3. By End User

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Sterilization Type

            16.18.2.2. By Indicator Class

            16.18.2.3. By End User

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Sterilization Type

            16.19.2.2. By Indicator Class

            16.19.2.3. By End User

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Sterilization Type

            16.20.2.2. By Indicator Class

            16.20.2.3. By End User

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Sterilization Type

            16.21.2.2. By Indicator Class

            16.21.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Sterilization Type

        17.3.3. By Indicator Class

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. The 3M Company

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Steris Plc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Thermo Fisher Scientific, Inc.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Mesa Labs, Inc.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. McKesson Medical-Surgical Inc.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Crosstex International, Inc.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Propper Manufacturing Co., Inc.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Terragene S.A.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Andersen Products, Inc.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Getinge AB

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. GKE-GmbH

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

        18.1.12. Liofilchem S.r.l.

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

        18.1.13. Protak Scientific Ltd.

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

        18.1.14. ParaSure Limited

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

        18.1.15. Excelsior Scientific

            18.1.15.1. Overview

            18.1.15.2. Product Portfolio

            18.1.15.3. Profitability by Market Segments

            18.1.15.4. Sales Footprint

            18.1.15.5. Strategy Overview

                18.1.15.5.1. Marketing Strategy

        18.1.16. Siltex Australia Pvt. Ltd.

            18.1.16.1. Overview

            18.1.16.2. Product Portfolio

            18.1.16.3. Profitability by Market Segments

            18.1.16.4. Sales Footprint

            18.1.16.5. Strategy Overview

                18.1.16.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Sterilization Type, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Indicator Class, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Sterilization Type, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Indicator Class, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Sterilization Type, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Indicator Class, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Sterilization Type, 2018 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Indicator Class, 2018 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: South Asia Market Value (US$ Million) Forecast by Sterilization Type, 2018 to 2033

Table 19: South Asia Market Value (US$ Million) Forecast by Indicator Class, 2018 to 2033

Table 20: South Asia Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: East Asia Market Value (US$ Million) Forecast by Sterilization Type, 2018 to 2033

Table 23: East Asia Market Value (US$ Million) Forecast by Indicator Class, 2018 to 2033

Table 24: East Asia Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: Oceania Market Value (US$ Million) Forecast by Sterilization Type, 2018 to 2033

Table 27: Oceania Market Value (US$ Million) Forecast by Indicator Class, 2018 to 2033

Table 28: Oceania Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 30: MEA Market Value (US$ Million) Forecast by Sterilization Type, 2018 to 2033

Table 31: MEA Market Value (US$ Million) Forecast by Indicator Class, 2018 to 2033

Table 32: MEA Market Value (US$ Million) Forecast by End User , 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Sterilization Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Indicator Class, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End User , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Sterilization Type, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Sterilization Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Sterilization Type, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Indicator Class, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Indicator Class, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Indicator Class, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 17: Global Market Attractiveness by Sterilization Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Indicator Class, 2023 to 2033

Figure 19: Global Market Attractiveness by End User , 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Sterilization Type, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Indicator Class, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End User , 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Sterilization Type, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Sterilization Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Sterilization Type, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Indicator Class, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Indicator Class, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Indicator Class, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 37: North America Market Attractiveness by Sterilization Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Indicator Class, 2023 to 2033

Figure 39: North America Market Attractiveness by End User , 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Sterilization Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Indicator Class, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End User , 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Sterilization Type, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Sterilization Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Sterilization Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Indicator Class, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Indicator Class, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Indicator Class, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 57: Latin America Market Attractiveness by Sterilization Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Indicator Class, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End User , 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Sterilization Type, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Indicator Class, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by End User , 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Sterilization Type, 2018 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Sterilization Type, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Sterilization Type, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Indicator Class, 2018 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Indicator Class, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Indicator Class, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 77: Europe Market Attractiveness by Sterilization Type, 2023 to 2033

Figure 78: Europe Market Attractiveness by Indicator Class, 2023 to 2033

Figure 79: Europe Market Attractiveness by End User , 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: South Asia Market Value (US$ Million) by Sterilization Type, 2023 to 2033

Figure 82: South Asia Market Value (US$ Million) by Indicator Class, 2023 to 2033

Figure 83: South Asia Market Value (US$ Million) by End User , 2023 to 2033

Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: South Asia Market Value (US$ Million) Analysis by Sterilization Type, 2018 to 2033

Figure 89: South Asia Market Value Share (%) and BPS Analysis by Sterilization Type, 2023 to 2033

Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Sterilization Type, 2023 to 2033

Figure 91: South Asia Market Value (US$ Million) Analysis by Indicator Class, 2018 to 2033

Figure 92: South Asia Market Value Share (%) and BPS Analysis by Indicator Class, 2023 to 2033

Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Indicator Class, 2023 to 2033

Figure 94: South Asia Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 95: South Asia Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 97: South Asia Market Attractiveness by Sterilization Type, 2023 to 2033

Figure 98: South Asia Market Attractiveness by Indicator Class, 2023 to 2033

Figure 99: South Asia Market Attractiveness by End User , 2023 to 2033

Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033

Figure 101: East Asia Market Value (US$ Million) by Sterilization Type, 2023 to 2033

Figure 102: East Asia Market Value (US$ Million) by Indicator Class, 2023 to 2033

Figure 103: East Asia Market Value (US$ Million) by End User , 2023 to 2033

Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: East Asia Market Value (US$ Million) Analysis by Sterilization Type, 2018 to 2033

Figure 109: East Asia Market Value Share (%) and BPS Analysis by Sterilization Type, 2023 to 2033

Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Sterilization Type, 2023 to 2033

Figure 111: East Asia Market Value (US$ Million) Analysis by Indicator Class, 2018 to 2033

Figure 112: East Asia Market Value Share (%) and BPS Analysis by Indicator Class, 2023 to 2033

Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Indicator Class, 2023 to 2033

Figure 114: East Asia Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 115: East Asia Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 117: East Asia Market Attractiveness by Sterilization Type, 2023 to 2033

Figure 118: East Asia Market Attractiveness by Indicator Class, 2023 to 2033

Figure 119: East Asia Market Attractiveness by End User , 2023 to 2033

Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 121: Oceania Market Value (US$ Million) by Sterilization Type, 2023 to 2033

Figure 122: Oceania Market Value (US$ Million) by Indicator Class, 2023 to 2033

Figure 123: Oceania Market Value (US$ Million) by End User , 2023 to 2033

Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: Oceania Market Value (US$ Million) Analysis by Sterilization Type, 2018 to 2033

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Sterilization Type, 2023 to 2033

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Sterilization Type, 2023 to 2033

Figure 131: Oceania Market Value (US$ Million) Analysis by Indicator Class, 2018 to 2033

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Indicator Class, 2023 to 2033

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Indicator Class, 2023 to 2033

Figure 134: Oceania Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 135: Oceania Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 137: Oceania Market Attractiveness by Sterilization Type, 2023 to 2033

Figure 138: Oceania Market Attractiveness by Indicator Class, 2023 to 2033

Figure 139: Oceania Market Attractiveness by End User , 2023 to 2033

Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033

Figure 141: MEA Market Value (US$ Million) by Sterilization Type, 2023 to 2033

Figure 142: MEA Market Value (US$ Million) by Indicator Class, 2023 to 2033

Figure 143: MEA Market Value (US$ Million) by End User , 2023 to 2033

Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: MEA Market Value (US$ Million) Analysis by Sterilization Type, 2018 to 2033

Figure 149: MEA Market Value Share (%) and BPS Analysis by Sterilization Type, 2023 to 2033

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Sterilization Type, 2023 to 2033

Figure 151: MEA Market Value (US$ Million) Analysis by Indicator Class, 2018 to 2033

Figure 152: MEA Market Value Share (%) and BPS Analysis by Indicator Class, 2023 to 2033

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Indicator Class, 2023 to 2033

Figure 154: MEA Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 155: MEA Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 157: MEA Market Attractiveness by Sterilization Type, 2023 to 2033

Figure 158: MEA Market Attractiveness by Indicator Class, 2023 to 2033

Figure 159: MEA Market Attractiveness by End User , 2023 to 2033

Figure 160: MEA Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Cancer Biological Therapy Market

Published : December 2022

Healthcare

Biologic Excipients Market

Published : June 2022

Explore Healthcare Insights

View Reports